Related Experiment Video
Updated: Aug 23, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Novel Oxygen-Dependent Degradable Immunotoxin Regulated by the Ubiquitin-Proteasome System Reduces Nonspecific
Min Wei1, Anxiang Chen1, Jian Zhang1
1State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.
Abstract:
The use of bacterial toxins as antitumor agents has received considerable attention. Immunotoxins based on antigen recognition of single-chain antibodies have been widely explored for cancer therapy. Despite their impressive killing effect on tumor cells, immunotoxins still display unspecific toxicity with undesired side effects. High levels of hypoxia-inducible factor 1α (HIF-1α) are well-known indicators of hypoxia in cancer cells. In this study, different linkers were employed to fuse the immunotoxin DAB389-4D5 scFv (DS) with the oxygen-dependent degradation domain (ODDD) of HIF-1α, a domain selectively facilitating the accumulation of HIF-1α under hypoxia, to construct the oxygen-dependent degradable immunotoxin DS-ODDD (DSO). The engineered fusion protein DSO-2 containing a linker (G4S)3 possesses the best killing effect on cancer cells under hypoxia and displayed considerably reduced nonspecific toxicity to normal cells under normoxic conditions. Flow cytometry, immunofluorescence, and immunoblot analyses demonstrated that DSO-2 was degraded via the ubiquitin-proteasome pathway regulated by the oxygen-sensitive mechanism. Western blot analysis indicated that the degradation of DSO-2 significantly decreased the activation of apoptosis-related molecules in normal cells. The engineered immunotoxin with oxygen-sensing properties developed herein is a potential therapeutic agent for cancer treatment.
Insights
Engineered immunotoxins fuse bacterial toxins with oxygen-sensing domains to target cancer cells. This approach reduces side effects by degrading the toxin in normal cells, offering a promising cancer therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Bacterial toxins and immunotoxins are explored as antitumor agents.
- Immunotoxins show potent tumor cell killing but cause nonspecific toxicity.
- Hypoxia-inducible factor 1α (HIF-1α) indicates cancer cell hypoxia.
Purpose of the Study:
- To engineer an oxygen-dependent degradable immunotoxin (DS-ODDD) for cancer therapy.
- To reduce nonspecific toxicity of immunotoxins in normal cells.
- To investigate the degradation mechanism and therapeutic potential of the engineered immunotoxin.
Main Methods:
- Fusion of immunotoxin DAB389-4D5 scFv (DS) with HIF-1α's oxygen-dependent degradation domain (ODDD).
- Construction and testing of the engineered fusion protein DSO-2 with a (G4S)3 linker.
- Analysis of DSO-2 degradation via ubiquitin-proteasome pathway and its effect on apoptosis-related molecules.
Main Results:
- DSO-2 demonstrated potent cancer cell killing under hypoxia.
- DSO-2 exhibited significantly reduced nonspecific toxicity to normal cells under normoxic conditions.
- DSO-2 degradation is regulated by an oxygen-sensitive ubiquitin-proteasome pathway, decreasing apoptosis in normal cells.
Conclusions:
- The engineered oxygen-sensing immunotoxin DSO-2 is a potential therapeutic agent for cancer treatment.
- Targeted degradation of immunotoxins based on cellular oxygen levels can minimize side effects.
- This strategy offers a novel approach to enhance the safety and efficacy of immunotoxin-based cancer therapies.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Extrinsic Apoptotic Pathway
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

